TY - JOUR AU - Hollebecque, A; Meyer, T; Moore, K N TI - An open-label, multicohort, phase I/II study of nivolumab in patients with virus-associated tumors (CheckMate 358): Efficacy and safety in recurrent or metastatic (R/M) cervical, vaginal, and vulvar cancers JO - J Clin Oncol VL - 35 PY - 2017 DO - 10.1200/JCO.2017.35.15_suppl.5504 SP - 5504 EP - 5504 N1 - (15_suppl) ER -